Hammers CM, Stanley JR. Mechanisms of disease: pemphigus and bullous pemphigoid[J]. Annu Rev Pathol, 2016, 11: 175⁃197. DOI: 10.1146/annurev⁃pathol⁃012615⁃044313.
Amagai M, Komai A, Hashimoto T, et al. Usefulness of enzyme⁃linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus[J]. Br J Dermatol, 1999, 140(2): 351⁃357.
[4]
赵辨. 中国临床皮肤病学[M]. 南京: 江苏科学技术出版社, 2015: 833.
[5]
Weiss D, Ristl R, Griss J, et al. Autoantibody levels and clinical disease severity in patients with pemphigus: comparison of aggregated anti⁃desmoglein ELISA values and indirect immunofluorescence titres[J]. Acta Derm Venereol, 2015, 95(5): 559⁃564. DOI: 10.2340/00015555⁃2023.
[6]
Amagai M, Klaus⁃Kovtun V, Stanley J R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion[J]. Cell, 1991, 67(5): 869⁃877. DOI: 10.1016/0092⁃8674(91)90360⁃B.
[7]
Eyre RW, Stanley JR. Human autoantibodies against a desmosomal protein complex with a calcium⁃sensitive epitope are characteristic of pemphigus foliaceus patients[J]. J Exp Med, 1987, 165(6): 1719⁃1724. DOI: 10.1084/jem.165.6.1719.